OSCR

Integrated bioinformatics analysis of the shared molecular mechanisms between Parkinson's disease and COVID-19.

Overview

Authors: Yang Su1, Hui Ma1, Jiayuan Niu1, Dongnan Hou1, Liya Li1
ORCID iDs: Dongnan Hou, Liya Li
  1. Department of Anesthesiology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China
Institutions: Dalian Medical University (China)
Journal: mSphere, volume 11, issue 4, pages e00908-25
Dates: received 20 December 2025; accepted 4 March 2026; published online 3 April 2026; in print April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1128/msphere.00908-25 · PMID 41930954 · PMCID PMC13123704 · OpenAlex W7148821760
Open access: gold, a free copy (OpenAlex)
Categories: genetics / omics (modality), human (organism), other condition (population), Parkinson's (population), cellular / molecular (subfield)
Methods: Smoothing, state filtering, decompositions, Preprocessing, Statistics
Keywords: Parkinson’s disease, COVID-19, CHI3L1, scRNA-seq, cell-to-cell communication
MeSH: Computational Biology*, COVID-19*, Parkinson Disease*, Astrocytes, Brain, Cell Communication, Chitinase-3-Like Protein 1, Dopaminergic Neurons, Gene Expression Profiling, Gene Ontology, Humans, Protein Interaction Maps, SARS-CoV-2, Single-Cell Analysis, Single-Cell Gene Expression Analysis (* major topic)
Topic: Long-Term Effects of COVID-19 (Clinical Neurology, Medicine), according to OpenAlex
Funding: National Natural Science Foundation of China (82401743); Natural Science Foundation of Liaoning Province (2025-BS-0661, 2025-MSLH-179); Dalian "1+X" program of China (2024LCJSYL30)
Citations: not cited yet (Europe PMC); 47 references in the paper

Abstract

To investigate the shared molecular mechanisms between Parkinson’s disease (PD) and COVID-19 through integrated bioinformatics analysis and single-cell RNA sequencing (scRNA-seq). We conducted a comprehensive analysis of bulk RNA-seq data from publicly available databases, along with scRNA-seq data from brain tissues of COVID-19 patients. Differential expression analysis identified 725 differentially expressed genes (DEGs) in COVID-19 and 633 in PD samples. A total of 77 overlapping DEGs were identified, highlighting common pathways associated with neuroinflammation and dopaminergic neuron dysfunction. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses revealed significant enrichment in inflammation-related pathways. The protein-protein interaction network analysis identified CHI3L1 as a key gene linking PD and COVID-19. ScRNA-seq analysis revealed a significant increase in CHI3L1-expressing astrocytes in COVID-19 samples, indicating a potential mechanism by which COVID-19 may exacerbate PD symptoms. Furthermore, cell-cell communication analysis revealed enhanced interactions between astrocytes and microglia, excitatory neurons, or oligodendrocytes through signaling molecules such as phosphoprotein 1, CADM1, NCAM1, NRG, and NRXN1, suggesting that astrocytes play a central role in regulating neuronal excitability, synaptic plasticity, and immune responses in the context of COVID-19. These findings suggest a complex interplay between COVID-19 and PD, emphasizing the need for further investigation into the shared pathogenic mechanisms and potential therapeutic targets.

IMPORTANCE: This study demonstrates the critical role of neuroinflammation and dopaminergic neuron damage in the shared pathogenesis of COVID-19 and Parkinson’s disease. CHI3L1 emerges as a key target, highlighting its potential involvement in modulating neuroinflammatory pathways and synaptic plasticity. The functional significance of CHI3L1, along with its pathological relevance, warrants further investigation through larger studies. Additionally, the active intercellular communication among astrocytes, microglia, and excitatory neurons underscores the profound impact of COVID-19 on neural circuitry. Collectively, these results provide important insights into the mechanisms driving the neurodegenerative consequences of COVID-19, emphasizing the need for continued exploration of therapeutic interventions and the long-term neurological effects of viral infection.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Other data links

Data availability

The bulk-seq expression profile and relevant clinical data of PD and COVID-19 samples at various stages were collected from the Gene Expression Omnibus (GEO; https://www.ncbi.nlm.nih.gov/geo/) with accession numbers GSE184950 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE184950) and GSE182299 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE182299).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 5 authors, 5 keywords, 15 MeSH terms, 3 funders, 47 references.

Cite

This paper

Su, Y., Ma, H., Niu, J., Hou, D., & Li, L. (2026). Integrated bioinformatics analysis of the shared molecular mechanisms between Parkinson's disease and COVID-19. mSphere, 11(4), e00908-25. https://doi.org/10.1128/msphere.00908-25

BibTeX

@article{su2026integrated,
author = {Su, Yang and Ma, Hui and Niu, Jiayuan and Hou, Dongnan and Li, Liya},
title = {{Integrated bioinformatics analysis of the shared molecular mechanisms between Parkinson's disease and COVID-19}},
journal = {mSphere},
year = {2026},
month = apr,
volume = {11},
number = {4},
pages = {e00908--25},
publisher = {American Society for Microbiology (ASM)},
issn = {2379-5042},
doi = {10.1128/msphere.00908-25},
url = {https://doi.org/10.1128/msphere.00908-25},
pmid = {41930954},
pmcid = {PMC13123704}
}

RIS

TY - JOUR
AU - Su, Yang
AU - Ma, Hui
AU - Niu, Jiayuan
AU - Hou, Dongnan
AU - Li, Liya
TI - Integrated bioinformatics analysis of the shared molecular mechanisms between Parkinson's disease and COVID-19
T2 - mSphere
J2 - mSphere
PY - 2026
DA - 2026/04/03
VL - 11
IS - 4
SP - e00908
EP - 25
SN - 2379-5042
PB - American Society for Microbiology (ASM)
DO - 10.1128/msphere.00908-25
UR - https://doi.org/10.1128/msphere.00908-25
LA - en
ER -

CSL-JSON

{
"id": "10.1128/msphere.00908-25",
"type": "article-journal",
"title": "Integrated bioinformatics analysis of the shared molecular mechanisms between Parkinson's disease and COVID-19",
"container-title": "mSphere",
"author": [
{
"family": "Su",
"given": "Yang"
},
{
"family": "Ma",
"given": "Hui"
},
{
"family": "Niu",
"given": "Jiayuan"
},
{
"family": "Hou",
"given": "Dongnan"
},
{
"family": "Li",
"given": "Liya"
}
],
"container-title-short": "mSphere",
"volume": "11",
"issue": "4",
"page": "e00908-25",
"DOI": "10.1128/msphere.00908-25",
"PMID": "41930954",
"PMCID": "PMC13123704",
"ISSN": "2379-5042",
"publisher": "American Society for Microbiology (ASM)",
"URL": "https://doi.org/10.1128/msphere.00908-25",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
3
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41598-025-09417-w
Single nucleus RNA sequencing profile analysis to reveal cell type specific common molecular drivers of Parkinson's disease and therapeutic agents.
Journal: Scientific reports
In common: NCBI GEO GSE184950, Parkinson's, genetics / omics, cellular / molecular, 1 reference
[2] doi:10.1038/s41598-024-68585-3
Identifying MSMO1, ELOVL6, AACS, and CERS2 related to lipid metabolism as biomarkers of Parkinson's disease.
Journal: Scientific reports
In common: NCBI GEO GSE184950, Parkinson's, genetics / omics, 1 reference
[3] doi:10.1126/sciadv.adi8287 [code]
Molecular profiling of human substantia nigra identifies diverse neuron types associated with vulnerability in Parkinson's disease.
Journal: Science advances
In common: NCBI GEO GSE184950, Parkinson's, cellular / molecular, 1 reference
[4] doi:10.1038/s41531-025-01147-0 [code]
Neural networks reveal novel gene signatures in Parkinson disease from single-nuclei transcriptomes.
Journal: NPJ Parkinson's disease
In common: NCBI GEO GSE184950, Parkinson's, genetics / omics, cellular / molecular
[5] doi:10.1038/s41531-023-00527-8
Identification of PLOD3 and LRRN3 as potential biomarkers for Parkinson's disease based on integrative analysis.
Journal: NPJ Parkinson's disease
In common: NCBI GEO GSE184950, Parkinson's, genetics / omics
[6] doi:10.1038/s41467-025-62048-7 [code]
Hamsters with long COVID present distinct transcriptomic profiles associated with neurodegenerative processes in brainstem.
Journal: Nature communications
In common: genetics / omics, other condition, cellular / molecular, 3 references
[7] doi:10.1016/j.celrep.2023.112189
SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice.
Journal: Cell reports
In common: genetics / omics, other condition, cellular / molecular, 3 references
[8] doi:10.1016/j.ebiom.2023.104784 [code]
Long-COVID cognitive impairments and reproductive hormone deficits in men may stem from GnRH neuronal death.
Journal: EBioMedicine
In common: other condition, 3 references
[9] doi:10.1073/pnas.2530209123
Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: other condition, 3 references
[10] doi:10.1093/braincomms/fcae139 [code]
Tracts in the limbic system show microstructural alterations post COVID-19 recovery.
Journal: Brain communications
In common: other condition, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.